TY - JOUR T1 - Proceedings of the 2019 Canadian Inflammatory Myopathy Study Symposium: Clinical Trial Readiness in Myositis JF - The Journal of Rheumatology JO - J Rheumatol DO - 10.3899/jrheum.200480 SP - jrheum.200480 AU - Valérie Leclair AU - Océane Landon-Cardinal AU - Rohit Aggarwal AU - Nick Bansback AU - Craig Campbell AU - Brian M. Feldman AU - Martin Jarry AU - Suzan McNamara AU - Barbara White AU - Marie Hudson Y1 - 2020/06/15 UR - http://www.jrheum.org/content/early/2020/06/09/jrheum.200480.abstract N2 - The Canadian Inflammatory Myopathy Study (CIMS) is a multicenter prospective cohort recruiting in 8 centers across Canada. One of the aims of CIMS is to conduct and participate in clinical trials in autoimmune inflammatory myopathies (AIM). Conducting clinical trials in rare diseases such as AIM presents challenges. During this symposium, experts in the field presented different solutions to successfully conduct clinical trials in AIM, including the importance of collaboration and careful trial design, as well as training and mentoring of young investigators. ER -